Literature DB >> 28262917

Bed rest with and without hospitalisation in multiple pregnancy for improving perinatal outcomes.

Katharina da Silva Lopes1, Yo Takemoto2, Erika Ota3, Shinji Tanigaki4, Rintaro Mori1.   

Abstract

BACKGROUND: Strict or partial bed rest in hospital or at home is commonly recommended for women with multiple pregnancy to improve pregnancy outcomes. In order to advise women to rest in bed for any length of time, a policy for clinical practice needs to be supported by reliable evidence and weighed against possible adverse effects resulting from prolonged activity restriction.
OBJECTIVES: The objective of this review is to assess the effectiveness of bed rest in hospital or at home to improve perinatal outcomes in women with a multiple pregnancy. SEARCH
METHODS: We searched the Cochrane Pregnancy and Childbirth Group's Trials Register (30 May 2016), ClinicalTrials.gov, the WHO International Clinical Trials Registry Platform (ICTRP) (30 May 2016) and reference lists of retrieved studies. SELECTION CRITERIA: We selected all individual and cluster-randomised controlled trials evaluating the effect of strict or partial bed rest at home or in hospital compared with no activity restriction during multiple pregnancy. DATA COLLECTION AND ANALYSIS: Two review authors independently assessed trials for inclusion, extracted data and methodological quality. We evaluated the quality of the evidence using the GRADE approach and summarised it in 'Summary of findings' tables. MAIN
RESULTS: We included six trials, involving a total of 636 women with a twin or triplet pregnancy (total of 1298 babies). We assessed all of the included trials as having a low risk of bias for random sequence generation. Apart from one trial with an unclear risk of bias, we judged all remaining trials to be of low risk of bias for allocation concealment.Five trials (495 women and 1016 babies) compared strict bed rest in hospital with no activity restriction at home. There was no difference in the risk of very preterm birth (risk ratio (RR) 1.02, 95% confidence interval (CI) 0.66 to 1.58, five trials, 495 women, assuming complete correlation between twins/triplets, low-quality evidence), perinatal mortality (RR 0.65, 95% CI 0.35 to 1.21, five trials, 1016 neonates, assuming independence between twins/triplets, low-quality evidence) and low birthweight (RR 0.95, 95% CI 0.75 to 1.21, three trials, 502 neonates, assuming independence between twins/triplets, low-quality evidence). We observed no differences for the risk of small-for-gestational age (SGA) (RR 0.75, 95% CI 0.56 to 1.01, two trials, 293 women, assuming independence between twins/triplets, low-quality evidence) and prelabour preterm rupture of the membrane (PPROM) (RR 1.30, 95% CI 0.71 to 2.38, three trials, 276 women, low-quality evidence). However, strict bed rest in hospital was associated with increased spontaneous onset of labour (RR 1.05, 95% CI 1.02 to 1.09, P = 0.004, four trials, 488 women) and a higher mean birthweight (mean difference (MD) 136.99 g, 95% CI 39.92 to 234.06, P = 0.006, three trials, 314 women) compared with no activity restriction at home.Only one trial (141 women and 282 babies) compared partial bed rest in hospital with no activity restriction at home. There was no evidence of a difference in the incidence of very preterm birth (RR 2.30, 95% CI 0.84 to 6.27, 141 women, assuming complete correlation between twins, low-quality evidence) and perinatal mortality (RR 4.17, 95% CI 0.90 to 19.31, 282 neonates, assuming complete independence twins, low-quality evidence) between the intervention and control group. Low birthweight was not reported in this trial. We found no differences in the risk of PPROM and SGA between women receiving partial bed rest and the control group (low-quality evidence). Women on partial bed rest in hospital were less likely to develop gestational hypertension compared with women without activity restriction at home (RR 0.30, 95% CI 0.16 to 0.59, P = 0.0004, 141 women).Strict or partial bed rest in hospital was found to have no impact on other secondary outcomes. None of the trials reported on costs of the intervention or adverse effects such as the development of venous thromboembolism or psychosocial effects. AUTHORS'
CONCLUSIONS: The evidence to date is insufficient to inform a policy of routine bed rest in hospital or at home for women with a multiple pregnancy. There is a need for large-scale, multicenter randomised controlled trials to evaluate the benefits, adverse effects and costs of bed rest before definitive conclusions can be drawn.

Entities:  

Mesh:

Year:  2017        PMID: 28262917      PMCID: PMC6464520          DOI: 10.1002/14651858.CD012031.pub2

Source DB:  PubMed          Journal:  Cochrane Database Syst Rev        ISSN: 1361-6137


  41 in total

Review 1.  Hospitalisation and bed rest for multiple pregnancy.

Authors:  C A Crowther
Journal:  Cochrane Database Syst Rev       Date:  2001

2.  Observations on foetal growth in multiple pregnancy in man.

Authors:  T MCKEOWN; R G RECORD
Journal:  J Endocrinol       Date:  1952-10       Impact factor: 4.286

Review 3.  The developmental origins of adult disease.

Authors:  D J P Barker
Journal:  J Am Coll Nutr       Date:  2004-12       Impact factor: 3.169

Review 4.  Bed rest with and without hospitalisation in multiple pregnancy for improving perinatal outcomes.

Authors:  Katharina da Silva Lopes; Yo Takemoto; Erika Ota; Shinji Tanigaki; Rintaro Mori
Journal:  Cochrane Database Syst Rev       Date:  2017-03-06

5.  [The value of bed rest and beta-sympathomimetic treatment in multiple pregnancies].

Authors:  M Gummerus; O Halonen
Journal:  Duodecim       Date:  1985

6.  Pregnancy-related mortality among women with multifetal pregnancies.

Authors:  Andrea P MacKay; Cynthia J Berg; Jeffrey C King; Catherine Duran; Jeani Chang
Journal:  Obstet Gynecol       Date:  2006-03       Impact factor: 7.661

Review 7.  Hospitalisation and bed rest for multiple pregnancy.

Authors:  Caroline A Crowther; Shanshan Han
Journal:  Cochrane Database Syst Rev       Date:  2010-07-07

8.  The prevalence of thromboembolic events among women with extended bed rest prescribed as part of the treatment for premature labor or preterm premature rupture of membranes.

Authors:  G J Kovacevich; S A Gaich; J P Lavin; M P Hopkins; S S Crane; J Stewart; D Nelson; L M Lavin
Journal:  Am J Obstet Gynecol       Date:  2000-05       Impact factor: 8.661

Review 9.  Rest during pregnancy for preventing pre-eclampsia and its complications in women with normal blood pressure.

Authors:  S Meher; L Duley
Journal:  Cochrane Database Syst Rev       Date:  2006-04-19

Review 10.  Bed rest with or without hospitalisation for hypertension during pregnancy.

Authors:  S Meher; E Abalos; G Carroli
Journal:  Cochrane Database Syst Rev       Date:  2005-10-19
View more
  9 in total

Review 1.  Bed rest with and without hospitalisation in multiple pregnancy for improving perinatal outcomes.

Authors:  Katharina da Silva Lopes; Yo Takemoto; Erika Ota; Shinji Tanigaki; Rintaro Mori
Journal:  Cochrane Database Syst Rev       Date:  2017-03-06

2.  Prevention and Therapy of Preterm Birth. Guideline of the DGGG, OEGGG and SGGG (S2k Level, AWMF Registry Number 015/025, February 2019) - Part 2 with Recommendations on the Tertiary Prevention of Preterm Birth and the Management of Preterm Premature Rupture of Membranes.

Authors:  Richard Berger; Harald Abele; Franz Bahlmann; Ivonne Bedei; Klaus Doubek; Ursula Felderhoff-Müser; Herbert Fluhr; Yves Garnier; Susanne Grylka-Baeschlin; Hanns Helmer; Egbert Herting; Markus Hoopmann; Irene Hösli; Udo Hoyme; Alexandra Jendreizeck; Harald Krentel; Ruben Kuon; Wolf Lütje; Silke Mader; Holger Maul; Werner Mendling; Barbara Mitschdörfer; Tatjana Nicin; Monika Nothacker; Dirk Olbertz; Werner Rath; Claudia Roll; Dietmar Schlembach; Ekkehard Schleußner; Florian Schütz; Vanadin Seifert-Klauss; Susanne Steppat; Daniel Surbek
Journal:  Geburtshilfe Frauenheilkd       Date:  2019-08-12       Impact factor: 2.915

3.  Hypertrophic cardiomyopathy and exercise: a need for more information.

Authors:  Michael J Joyner
Journal:  J Physiol       Date:  2019-02-03       Impact factor: 5.182

4.  Society for Maternal-Fetal Medicine Consult Series #50: The role of activity restriction in obstetric management: (Replaces Consult Number 33, August 2014).

Authors:  Jhenette Lauder; Anthony Sciscione; Joseph Biggio; Sarah Osmundson
Journal:  Am J Obstet Gynecol       Date:  2020-04-29       Impact factor: 8.661

5.  Provider advice on physical activity and nutrition in twin pregnancies: a cross-sectional electronic survey.

Authors:  Kara M Whitaker; Meghan Baruth; Rebecca A Schlaff; Hailee Talbot; Christopher P Connolly; Jihong Liu; Sara Wilcox
Journal:  BMC Pregnancy Childbirth       Date:  2019-11-14       Impact factor: 3.007

6.  Physical Activity Behaviors and Barriers in Multifetal Pregnancy: What to Expect When You're Expecting More.

Authors:  Victoria L Meah; Morgan C Strynadka; Rshmi Khurana; Margie H Davenport
Journal:  Int J Environ Res Public Health       Date:  2021-04-08       Impact factor: 3.390

7.  Gestational age-based reference ranges for cervical length and preterm birth prediction in triplet pregnancies: an observational retrospective study.

Authors:  Carlota Rodo; María de la Calle; Anna Maroto; Nerea Maiz; Silvia Arévalo; Pablo Garcia-Manau; Manel Mendoza; José Luis Bartha; Elena Carreras
Journal:  BMC Pregnancy Childbirth       Date:  2022-08-30       Impact factor: 3.105

8.  Interventions during pregnancy to prevent preterm birth: an overview of Cochrane systematic reviews.

Authors:  Nancy Medley; Joshua P Vogel; Angharad Care; Zarko Alfirevic
Journal:  Cochrane Database Syst Rev       Date:  2018-11-14

9.  Arabin cervical pessary for prevention of preterm birth in cases of twin-to-twin transfusion syndrome treated by fetoscopic LASER coagulation: the PECEP LASER randomised controlled trial.

Authors:  Carlota Rodó; Sílvia Arévalo; Liesbeth Lewi; Isabel Couck; Bettina Hollwitz; Kurt Hecher; Elena Carreras
Journal:  BMC Pregnancy Childbirth       Date:  2017-08-01       Impact factor: 3.007

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.